You are here: Industry Insights > Novartis

News List

Roche completed the repurchase of Roche shares from Novartis WorldPharmaNews
December 07, 2021
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it completed the repurchase of Roche shares that had been held by Novartis. On 4 November 2021, Roche and Novartis had announced this repurchase. The Extraordinary General Meeting of Roche Holding...
UCB and Novartis to co-develop two drug candidates for Parkinson’s Disease Pharmaceutical-Technology
December 06, 2021
Belgian pharmaceutical firm UCB has signed an agreement with Novartis to develop disease-modifying treatments for Parkinson’s Disease (PD) patients.
ClinTex (CTi) launches CTi-OEM blockchain clinical trial app expresspharma
August 06, 2021
The ClinTex (CTi) tokenised platform will utilise blockchain-based clinical data analytics to address the main causes of clinical trial inefficiency, helping to drive down the cost of new medicines and expediting their delivery to patients ...
Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol® prnasia
August 04, 2021
Yuyu Pharma, a pharmaceutical company based in Korea, and Novartis Korea announced that the companies have entered into an agreement in which Yuyu will have exclusive distribution rights for the following prescription medicines in Korea: Lamisil® for ...
Novartis Announces New Phase 3 Study for Spinal Muscular Atrophy Treatment in Elderly Patients americanpharmaceuticalreview
August 04, 2021
Novartis announced that the U.S. FDA determined that OAV-101 intrathecal (IT) clinical trials for spinal muscular atrophy (SMA) patients may proceed, thereby lifting the partial clinical trial hold initiated in October 2019.
Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry worldpharmanews
July 23, 2021
Board level executives from Novartis, Bayer and Boehringer Ingelheim, amongst many more, will showcase their long-term visions for healthcare as a response to the COVID-19 pandemic, by joining the speaker faculty at Reuters Events Pharma Europe 2021.
Novartis Pledges 10-Year Commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools americanpharmaceuticalreview
July 21, 2021
Novartis and the Novartis US Foundation announced a 10-year collaboration with Coursera, the National Medical Association, Thurgood Marshall College Fund, Morehouse School of Medicine and 26 additional Historically Black Colleges, Universities and ...
The Scottish Medicines Consortium recommends Novartis’ Kesimpta (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS) firstwordpharma
July 14, 2021
Novartis today announced that eligible patients in Scotland will soon have access to Kesimpta® (ofatumumab), the first self-administered, targeted B-cell therapy for patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined b
Novartis shifts Leqvio manufacturing to Austrian facility cphi-online
July 08, 2021
Pharma firm tells FDA tech transfer to its own facility in Schaftenau, Austria is underway after regulator highlighted concerns about third party CDMO site in Italy
Novartis to manufacture anti-cholesterol drug Leqvio for US in Austria due to delay in US clearance expresspharma
July 07, 2021
US clearance stalled after the US FDA questioned "unresolved facility inspection-related conditions" at the Italian plant of Novartis supplier Corden Pharma.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 71 72 Next page